Crisnatol BWA770U,99.51%
产品编号:Bellancom-108999A| CAS NO:96389-68-3| 分子式:C23H23NO2| 分子量:345.43
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Crisnatol BWA770U
产品介绍 | Crisnatol (BWA770U) 是一种口服有效的抗癌剂和芳甲基氨基丙二醇类 DNA 插入器。Crisnatol 对人类乳腺癌细胞显示出体外细胞毒性,但对正常的人类皮肤成纤维细胞无效。 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
生物活性 | Crisnatol (BWA770U) is an orally active and anticancer agent, and a member of the arylmethylaminopropanediol class of DNA intercalators. Crisnatol shows in vitro cytotoxicity against human breast cancer cells, but not normal human skin fibroblasts. | ||||||||||||||||
体外研究 |
Crisnatol (1.3 μg/mL; 24-72 h) 抑制 HepG2 细胞的复制,使细胞活力降低 35%。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay
|
||||||||||||||||
体内研究 (In Vivo) |
Crisnatol (25 mg/kg; p.o.; single dose) 显示出口服活性,并通过放射自显影显示大鼠粪便提取物的稳定代谢物谱。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Crisnatol (25 mg/kg; p.o.; single dose) 显示出口服活性,并通过放射自显影显示大鼠粪便提取物的稳定代谢物谱。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
体内研究 |
Crisnatol (25 mg/kg; p.o.; single dose) 显示出口服活性,并通过放射自显影显示大鼠粪便提取物的稳定代谢物谱。 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
性状 | Solid | ||||||||||||||||
溶解性数据 |
In Vitro:
DMSO : 100 mg/mL (289.49 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
参考文献 |
|